$SRRE
SUNRISE REAL ESTATE GROUP INC

2024 Q2 Form 10-K Financial Statement

#000141057824000987 Filed on June 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $4.448M $6.660M $24.83M
YoY Change -36.84% -38.97% -68.97%
Cost Of Revenue $3.759M $4.097M $19.89M
YoY Change -36.88% -57.89% -71.81%
Gross Profit $689.0K $2.563M $4.944M
YoY Change -36.58% 116.73% -47.71%
Gross Profit Margin 15.49% 38.48% 19.91%
Selling, General & Admin $684.6K $1.502M $3.756M
YoY Change -6.05% -74.71% -56.08%
% of Gross Profit 99.36% 58.59% 75.96%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $504.8K $417.6K $1.724M
YoY Change -170.91% -5.33% -3.15%
% of Gross Profit 73.26% 16.29% 34.86%
Operating Expenses $1.038M $1.853M $5.558M
YoY Change -14.82% -75.17% -52.0%
Operating Profit -$349.2K $710.2K -$613.9K
YoY Change 163.88% -111.31% -71.08%
Interest Expense -$495.5K -$1.420M -$2.394M
YoY Change -7.2% -168.76% -6084.0%
% of Operating Profit -199.87%
Other Income/Expense, Net -$3.767M -$1.404M -$24.55M
YoY Change -745.02% -754.03% 799.32%
Pretax Income -$4.116M -$22.84M -$25.17M
YoY Change -1011.33% 470.86% 418.53%
Income Tax $169.1K $555.8K $1.095M
% Of Pretax Income
Net Earnings -$3.600M -$7.915M -$10.13M
YoY Change -1152.62% 5.98% 20.2%
Net Earnings / Revenue -80.93% -118.84% -40.79%
Basic Earnings Per Share $0.05 -$0.15
Diluted Earnings Per Share $0.05 -$0.12 -$0.15
COMMON SHARES
Basic Shares Outstanding 68.69M 68.69M 68.69M
Diluted Shares Outstanding 68.69M 68.69M

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $42.92M $46.96M $46.96M
YoY Change 49.85% 6.33% 6.33%
Cash & Equivalents $27.71M $23.18M $20.45M
Short-Term Investments $17.42M $26.51M $26.51M
Other Short-Term Assets $91.46M $97.76M $97.76M
YoY Change -46.55% -43.16% -43.16%
Inventory
Prepaid Expenses
Receivables $191.1K $553.0K $553.0K
Other Receivables $16.10M $16.20M $19.23M
Total Short-Term Assets $153.7M $164.5M $164.5M
YoY Change -30.56% -30.23% -30.23%
LONG-TERM ASSETS
Property, Plant & Equipment $629.0K $728.1K $29.64M
YoY Change -23.21% -27.27% 25.19%
Goodwill $0.00
YoY Change -100.0%
Intangibles
YoY Change
Long-Term Investments $13.01M $13.09M $13.73M
YoY Change 5.86% 2.67% 2.46%
Other Assets
YoY Change
Total Long-Term Assets $42.12M $43.37M $43.37M
YoY Change 17.32% 13.18% 13.18%
TOTAL ASSETS
Total Short-Term Assets $153.7M $164.5M $164.5M
Total Long-Term Assets $42.12M $43.37M $43.37M
Total Assets $195.8M $207.9M $207.9M
YoY Change -23.88% -24.16% -24.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.64M $24.89M $24.89M
YoY Change -21.66% 11.23% 11.23%
Accrued Expenses $640.4K $480.4K $480.4K
YoY Change 42.8% -20.57% -20.57%
Deferred Revenue
YoY Change
Short-Term Debt $1.403M $1.412M $1.412M
YoY Change 1.39% -1.67% -1.67%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $89.49M $91.68M $91.68M
YoY Change -24.77% -28.53% -28.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $89.49M $91.68M $91.68M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $89.49M $91.68M $88.61M
YoY Change -25.11% -29.12% -37.85%
SHAREHOLDERS EQUITY
Retained Earnings $91.56M $99.17M
YoY Change -15.21% -9.27%
Common Stock $8.797M $8.797M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $110.8M $119.3M $119.3M
YoY Change
Total Liabilities & Shareholders Equity $195.8M $207.9M $207.9M
YoY Change -23.88% -24.16% -24.16%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$3.600M -$7.915M -$10.13M
YoY Change -1152.62% 5.98% 20.2%
Depreciation, Depletion And Amortization $504.8K $417.6K $1.724M
YoY Change -170.91% -5.33% -3.15%
Cash From Operating Activities -$622.0K $9.504M -$4.059M
YoY Change -95.29% -188.24% -69.19%
INVESTING ACTIVITIES
Capital Expenditures $17.32K $540.00 $6.032K
YoY Change 884.09% -121.43% -96.83%
Acquisitions
YoY Change
Other Investing Activities $4.383M -$18.59M -$15.80M
YoY Change -284.03% -161.72% -969.81%
Cash From Investing Activities $4.366M -$18.60M -$15.80M
YoY Change -283.17% -161.71% -1071.88%
FINANCING ACTIVITIES
Cash Dividend Paid $10.18M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -24.30M -24.30M
YoY Change -100.0% -682.59% -202.26%
NET CHANGE
Cash From Operating Activities -622.0K 9.504M -4.059M
Cash From Investing Activities 4.366M -18.60M -15.80M
Cash From Financing Activities 0.000 -24.30M -24.30M
Net Change In Cash 3.744M -33.39M -53.89M
YoY Change -131.9% -241.89% 549.29%
FREE CASH FLOW
Cash From Operating Activities -$622.0K $9.504M -$4.059M
Capital Expenditures $17.32K $540.00 $6.032K
Free Cash Flow -$639.3K $9.504M -$4.065M
YoY Change -95.16% -188.25% -69.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001083490
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2022 srre Impairment Of Other Investments
ImpairmentOfOtherInvestments
0
CY2023 srre Impairment Of Other Investments
ImpairmentOfOtherInvestments
0
CY2023Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
CY2022Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
CY2023 dei Security Exchange Name
SecurityExchangeName
NONE
CY2023 dei Entity Address Country
EntityAddressCountry
CN
CY2023 dei Entity Registrant Name
EntityRegistrantName
SUNRISE REAL ESTATE GROUP INC
CY2023Q4 us-gaap Investment Type Extensible Enumeration
InvestmentTypeExtensibleEnumeration
http://www.sunrise.sh/20231231#BankWealthManagementInvestmentProductsMember
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-32585
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TX
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-2713701
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
No. 18, Panlong Road
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Shanghai
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
201702
CY2023 dei Country Region
CountryRegion
86
CY2023 dei City Area Code
CityAreaCode
21
CY2023 dei Local Phone Number
LocalPhoneNumber
6139-8018
CY2023 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2023 dei Trading Symbol
TradingSymbol
SRRE
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
5980573
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68691925
CY2023 dei Auditor Name
AuditorName
RH CPA
CY2023 dei Auditor Firm
AuditorFirmId
6398
CY2023 dei Auditor Location
AuditorLocation
Bayside, NY
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
20453464
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
33201354
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
2723667
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
43869156
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
26505532
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
10960511
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
552964
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
204518
CY2023Q4 us-gaap Land Available For Development
LandAvailableForDevelopment
88742269
CY2022Q4 us-gaap Land Available For Development
LandAvailableForDevelopment
120302022
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
16203433
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
16502409
CY2023Q4 srre Other Receivables And Deposit Net Current
OtherReceivablesAndDepositNetCurrent
9321913
CY2022Q4 srre Other Receivables And Deposit Net Current
OtherReceivablesAndDepositNetCurrent
10733460
CY2023Q4 us-gaap Assets Current
AssetsCurrent
164503242
CY2022Q4 us-gaap Assets Current
AssetsCurrent
235773430
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
728094
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1001077
CY2023Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
28910575
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
22673139
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
13091335
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
12751061
CY2023Q4 us-gaap Other Investments
OtherInvestments
641810
CY2022Q4 us-gaap Other Investments
OtherInvestments
652693
CY2022Q4 us-gaap Goodwill
Goodwill
1243194
CY2023Q4 us-gaap Assets
Assets
207875056
CY2022Q4 us-gaap Assets
Assets
274094594
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1411891
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1435833
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
24885181
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22372938
CY2023Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
23318011
CY2022Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
34742361
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7352352
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7587515
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
247516
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
255175
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
10303789
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1926888
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1848666
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
91682684
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
128277659
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1078422
CY2023Q4 us-gaap Liabilities
Liabilities
91682684
CY2022Q4 us-gaap Liabilities
Liabilities
129356081
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68691925
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68691925
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68691925
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68691925
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
686919
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
686919
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8110008
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8110008
CY2023Q4 us-gaap Statutory Accounting Practices Retained Earnings Not Available For Dividends
StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends
3986618
CY2022Q4 us-gaap Statutory Accounting Practices Retained Earnings Not Available For Dividends
StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends
3986618
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
99169737
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
109300636
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7311786
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
9447265
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
119265068
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
131531446
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-3072696
CY2022Q4 us-gaap Minority Interest
MinorityInterest
13207067
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
116192372
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
144738513
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
207875056
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
274094594
CY2023 us-gaap Revenues
Revenues
24833863
CY2022 us-gaap Revenues
Revenues
80020189
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
19889480
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
70563802
CY2023 us-gaap Gross Profit
GrossProfit
4944383
CY2022 us-gaap Gross Profit
GrossProfit
9456387
CY2023 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1802558
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3029088
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3755767
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8550561
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-613942
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-2123262
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
832461
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
691096
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3226658
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-651085
CY2023 srre Impairment Of Real Estate Property Under Development
ImpairmentOfRealEstatePropertyUnderDevelopment
19590407
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1132629
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1435287
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2770136
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-24552520
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2730125
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25166462
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4853387
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1095356
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4542509
CY2023 us-gaap Profit Loss
ProfitLoss
-26261818
CY2022 us-gaap Profit Loss
ProfitLoss
-9395896
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-16130919
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-967308
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-10130899
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-8428588
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68691925
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68691925
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68691925
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68691925
CY2023 us-gaap Profit Loss
ProfitLoss
-26261818
CY2022 us-gaap Profit Loss
ProfitLoss
-9395896
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2284323
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16547215
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-28546141
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-25943111
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-16279763
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2223365
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12266378
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23719746
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
170621624
CY2022 us-gaap Profit Loss
ProfitLoss
-9395896
CY2022 srre Company Cancellation
CompanyCancellation
0
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
60000
CY2022 us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
16547215
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
144738513
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
144738513
CY2023 us-gaap Profit Loss
ProfitLoss
-26261818
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
2284323
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
116192372
CY2023 us-gaap Profit Loss
ProfitLoss
-26261818
CY2022 us-gaap Profit Loss
ProfitLoss
-9395896
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1723524
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1779670
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-34020
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-27559
CY2023 srre Bad Debts Recovered
BadDebtsRecovered
-804919
CY2023 srre Impairment Of Real Estate Property Under Development
ImpairmentOfRealEstatePropertyUnderDevelopment
19590407
CY2023 srre Goodwill Impairment Loss Operating Activities
GoodwillImpairmentLossOperatingActivities
1243194
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
353443
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
149204
CY2023 srre Increase Decrease In Net Cash From Directors
IncreaseDecreaseInNetCashFromDirectors
-1
CY2022 srre Increase Decrease In Net Cash From Directors
IncreaseDecreaseInNetCashFromDirectors
891
CY2023 srre Increase Decrease In Real Estate Property Under Development
IncreaseDecreaseInRealEstatePropertyUnderDevelopment
-10096668
CY2022 srre Increase Decrease In Real Estate Property Under Development
IncreaseDecreaseInRealEstatePropertyUnderDevelopment
-44764605
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-10893953
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-83545766
CY2023 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
2292261
CY2022 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-29472050
CY2023 srre Increase Decrease In Other Receivables And Deposits
IncreaseDecreaseInOtherReceivablesAndDeposits
-433213
CY2022 srre Increase Decrease In Other Receivables And Deposits
IncreaseDecreaseInOtherReceivablesAndDeposits
-3330221
CY2022 srre Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
-808115
CY2022 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-901258
CY2023 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
2898312
CY2022 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-644540
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-109135
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-502641
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-968883
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
99955
CY2023 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
-3419
CY2022 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
-119403
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4058654
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13174908
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6032
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
190148
CY2023 srre Proceeds From Transactional Financial Assets
ProceedsFromTransactionalFinancialAssets
-15798715
CY2022 srre Proceeds From Transactional Financial Assets
ProceedsFromTransactionalFinancialAssets
1816348
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15804747
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1626200
CY2023 srre Proceeds From Affiliate
ProceedsFromAffiliate
-14118909
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
10177675
CY2022 srre Increase Decrease On Restricted Cash
IncreaseDecreaseOnRestrictedCash
-23759027
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24296584
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23759027
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-9733394
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3910009
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-53893379
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8300010
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77070510
CY2021Q4 srre Cash And Cash Equivalents Excluding Restricted Cash
CashAndCashEquivalentsExcludingRestrictedCash
24901044
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23177131
CY2022Q4 srre Cash And Cash Equivalents Excluding Restricted Cash
CashAndCashEquivalentsExcludingRestrictedCash
33201354
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
2095507
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
4542509
CY2023 us-gaap Interest Paid Net
InterestPaidNet
1159475
CY2022 us-gaap Interest Paid Net
InterestPaidNet
1485288
CY2022Q4 srre Foreign Exchange Currency Translation Rate
ForeignExchangeCurrencyTranslationRate
1
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in accordance with U.S GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Concentrations of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, accounts receivable, other receivables and deposits, and amount due from an unconsolidated affiliate. The Company places its cash and cash equivalents with reputable financial institutions with high credit ratings.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company conducts credit evaluations of customers and generally does not require collateral or other security from customers. The Company establishes an allowance for doubtful accounts primarily based upon the age of the receivables and factors relevant to determining the credit risk of specific customers. The amount of receivables ultimately not collected by the Company has generally been consistent with management’s expectations and the allowance established for doubtful accounts.</p>
CY2022Q4 srre Number Of Customer
NumberOfCustomer
0
CY2023Q4 srre Number Of Customer
NumberOfCustomer
0
CY2022 srre Concentration Risk Threshold Percentage
ConcentrationRiskThresholdPercentage
0.10
CY2023 srre Concentration Risk Threshold Percentage
ConcentrationRiskThresholdPercentage
0.10
CY2023Q4 srre Foreign Exchange Currency Translation Rate
ForeignExchangeCurrencyTranslationRate
1
CY2023Q4 srre Foreign Exchange Currency Translation Rate
ForeignExchangeCurrencyTranslationRate
7.0827
CY2022Q4 srre Foreign Exchange Currency Translation Rate
ForeignExchangeCurrencyTranslationRate
6.9646
CY2023 srre Impairment Of Real Estate Property Under Development
ImpairmentOfRealEstatePropertyUnderDevelopment
19600000
CY2023Q4 srre Accumulated Impairment Loss Of Real Estate Property Under Development
AccumulatedImpairmentLossOfRealEstatePropertyUnderDevelopment
19600000
CY2023 srre Real Estate Investment Property Estimated Useful Lives
RealEstateInvestmentPropertyEstimatedUsefulLives
20 years
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2023 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1132629
CY2023Q4 us-gaap Goodwill
Goodwill
0
CY2023 srre Significant Influence Percentage Description
SignificantInfluencePercentageDescription
0.20
CY2022 srre Impairment Loss On Investments Unconsolidated Affiliates
ImpairmentLossOnInvestmentsUnconsolidatedAffiliates
0
CY2023 srre Impairment Loss On Investments Unconsolidated Affiliates
ImpairmentLossOnInvestmentsUnconsolidatedAffiliates
0
CY2022 srre Impairment Of Other Investments
ImpairmentOfOtherInvestments
0
CY2023 srre Impairment Of Other Investments
ImpairmentOfOtherInvestments
0
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
24885181
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
2723667
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
43869156
CY2023Q4 us-gaap Deferred Rent Asset Net Current
DeferredRentAssetNetCurrent
719354
CY2022Q4 us-gaap Deferred Rent Asset Net Current
DeferredRentAssetNetCurrent
735860
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
48462
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
28153
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
6242218
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
7783185
CY2023Q4 srre Other Other Receivables Current
OtherOtherReceivablesCurrent
2283757
CY2022Q4 srre Other Other Receivables Current
OtherOtherReceivablesCurrent
1859000
CY2023Q4 srre Other Receivables And Deposit Net Current
OtherReceivablesAndDepositNetCurrent
9321913
CY2022Q4 srre Other Receivables And Deposit Net Current
OtherReceivablesAndDepositNetCurrent
10733460
CY2023Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
1265984
CY2022Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
1233179
CY2023Q4 srre Other Other Receivables Current
OtherOtherReceivablesCurrent
2283757
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22372938
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3195199
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3278646
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2467105
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2277569
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
728094
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1001077
CY2023Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
41123783
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
33367887
CY2023Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
12213208
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
10694748
CY2023Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
28910575
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
22673139
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1495096
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1495096
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
100289
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
178251
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2023Q4 srre Due To Due From Officers Or Stockholders Current
DueToDueFromOfficersOrStockholdersCurrent
472104
CY2022Q4 srre Due To Due From Officers Or Stockholders Current
DueToDueFromOfficersOrStockholdersCurrent
480109
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
44572
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
185124
CY2023Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
188355
CY2022Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
164566
CY2023Q4 srre Accrued Bid Bond Current
AccruedBidBondCurrent
78763
CY2022Q4 srre Accrued Bid Bond Current
AccruedBidBondCurrent
90457
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
6850685
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
6954170
CY2023Q4 srre Dividends Payable To Non Controlling Interest Current
DividendsPayableToNonControllingInterestCurrent
189977
CY2022Q4 srre Dividends Payable To Non Controlling Interest Current
DividendsPayableToNonControllingInterestCurrent
193198
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7352352
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7587515
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-3479331
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
35509699
CY2023 srre Income Tax Expenses
IncomeTaxExpenses
1095356
CY2022 srre Income Tax Expenses
IncomeTaxExpenses
5569826
CY2017Q4 srre Income Tax Expenses
IncomeTaxExpenses
0
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.315
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
-0.334
CY2023 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.000
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.315
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.1569
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
0
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
0
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
0
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
0
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
27919
CY2023Q4 srre Lessee Operating Lease Liability Payments Due Year Two To Five
LesseeOperatingLeaseLiabilityPaymentsDueYearTwoToFive
0
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
27919
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001410578-24-000987-index-headers.html Edgar Link pending
0001410578-24-000987-index.html Edgar Link pending
0001410578-24-000987.txt Edgar Link pending
0001410578-24-000987-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
srre-20231231.xsd Edgar Link pending
srre-20231231x10k.htm Edgar Link pending
srre-20231231x10k001.jpg Edgar Link pending
srre-20231231xex31d1.htm Edgar Link pending
srre-20231231xex31d2.htm Edgar Link pending
srre-20231231xex32d1.htm Edgar Link pending
srre-20231231xex32d2.htm Edgar Link pending
srre-20231231xex4d1.htm Edgar Link pending
srre-20231231_cal.xml Edgar Link unprocessable
srre-20231231_def.xml Edgar Link unprocessable
srre-20231231_pre.xml Edgar Link unprocessable
srre-20231231_lab.xml Edgar Link unprocessable
srre-20231231x10k_htm.xml Edgar Link completed